M-J Ahn Selected Research

M-J Ahn Research Topics

Disease

13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 04/2015
12	Neoplasms (Cancer) 06/2023 - 01/2015
6	Exanthema (Rash) 01/2022 - 05/2015
4	Neoplasm Metastasis (Metastasis) 11/2023 - 04/2015
4	Lung Neoplasms (Lung Cancer) 01/2021 - 06/2017
3	Squamous Cell Carcinoma of Head and Neck 12/2023 - 11/2019
3	Brain Neoplasms (Brain Tumor) 11/2023 - 04/2015
3	Disease Progression 01/2023 - 01/2020
3	Fatigue 01/2022 - 05/2015
3	Diarrhea 11/2020 - 05/2015
3	Nausea 11/2020 - 05/2015
2	Esophageal Squamous Cell Carcinoma 01/2022 - 01/2016
2	Vomiting 01/2020 - 05/2015
2	Hypertension (High Blood Pressure) 01/2017 - 05/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2013 - 12/2006
1	Carcinoma (Carcinomatosis) 06/2023
1	Nasopharyngeal Carcinoma 01/2023
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023
1	Pruritus (Itching) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Leukopenia 11/2019
1	Acne Vulgaris 11/2019
1	Epilepsy (Aura) 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2017
1	Asthenia 05/2015
1	Central Nervous System Diseases (CNS Diseases) 04/2015
1	Fever (Fevers) 08/2013
1	Infections 08/2004
1	Necrosis 08/2004

Drug/Important Bio-Agent (IBA)

6	pembrolizumabIBA 12/2023 - 01/2017
5	PlatinumIBA 12/2023 - 11/2019
5	B7-H1 AntigenIBA 01/2023 - 01/2016
5	osimertinibIBA 11/2020 - 01/2018
3	Docetaxel (Taxotere)FDA Link 12/2023 - 05/2015
3	ErbB Receptors (EGF Receptor)IBA 11/2023 - 10/2020
3	durvalumabIBA 01/2023 - 01/2020
2	Cetuximab (Erbitux)FDA Link 12/2023 - 01/2023
2	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 11/2019
2	Cisplatin (Platino)FDA LinkGeneric 06/2023 - 12/2006
2	Tyrosine Kinase InhibitorsIBA 11/2020 - 10/2020
1	Gefitinib (Iressa)FDA Link 11/2023
1	dacomitinibIBA 11/2023
1	avelumabIBA 06/2023
1	Axitinib (AG 013736)IBA 06/2023
1	Fluorouracil (Carac)FDA LinkGeneric 01/2023
1	tremelimumabIBA 01/2023
1	CTLA-4 AntigenIBA 01/2023
1	entrectinibIBA 01/2021
1	Pemetrexed (MTA)FDA Link 11/2020
1	AZD 6244IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	AfatinibIBA 11/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 06/2017
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 06/2017
1	vandetanib (ZD6474)IBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2017
1	trametinibIBA 05/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2004
1	Interleukin-6 (Interleukin 6)IBA 08/2004
1	CytokinesIBA 08/2004
1	Interleukin-8 (Interleukin 8)IBA 08/2004
1	NF-kappa B (NF-kB)IBA 08/2004
1	I-kappa B KinaseIBA 08/2004
1	InterleukinsIBA 08/2004

Therapy/Procedure

8	Therapeutics 12/2023 - 05/2015
6	Drug Therapy (Chemotherapy) 12/2023 - 08/2013
2	Chemoradiotherapy 01/2022 - 01/2016
2	Radiotherapy 11/2019 - 08/2013
1	Neoadjuvant Therapy 01/2022
1	Immunotherapy 01/2020
1	Semiconductors 01/2015